These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 8584043)

  • 1. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
    Borsini F; Ceci A; Bietti G; Donetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.
    Borsini F; Giraldo E; Monferini E; Antonini G; Parenti M; Bietti G; Donetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):276-82. PubMed ID: 8584042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.
    Hajós M; Hajós-Korcsok E; Sharp T
    Br J Pharmacol; 1999 Apr; 126(8):1741-50. PubMed ID: 10372816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
    Winsauer PJ; Moerschbaecher JM
    Behav Pharmacol; 2000 Nov; 11(7-8):535-53. PubMed ID: 11198126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.
    Jolas T; Haj-Dahmane S; Lanfumey L; Fattaccini CM; Kidd EJ; Adrien J; Gozlan H; Guardiola-Lemaitre B; Hamon M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):453-63. PubMed ID: 7686633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.
    Arborelius L; Chergui K; Murase S; Nomikos GG; Höök BB; Chouvet G; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr; 347(4):353-62. PubMed ID: 8510763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M; Samanin R
    Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MKC-242, a novel 5-HT1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats.
    Somboonthum P; Matsuda T; Asano S; Sakaue M; Baba A
    Neuropharmacology; 1997; 36(11-12):1733-9. PubMed ID: 9517445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
    Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
    Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.